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Mucosal hypoxia is intimately associated with chronic inflam-
mation in the gastrointestinal tract in disease such as Crohn’s
disease. Under such conditions, intestinal epithelial cells may
become a source of proinflammatory cytokines, including tumor
necrosis factor a (TNFa), which actively contribute to ongoing
inflammation through autocrine disruption of epithelial barrier
function. These events are critically dependent upon alterations
in the expression and function of the cAMF response element
binding protein (CREB). Here we review our understanding of
the molecular mechanisms underlying the regulation of CREB
activity in intestinal epithelial cells in hypoxia.
Under normal physiologic conditions, differential lev-
els of tissue oxygenation exist throughout the body. PO2
values range from around 107 mm Hg at highly oxy-
genated mucosal tissues such as the pulmonary alveoli
to around 36 mm Hg at intestinal mucosal surfaces [1–
3]. The supply of oxygen to a tissue is largely dependent
upon vascularization, vasodialation, and the oxygenation
of blood at that site while oxygen demand is largely de-
termined by the rate of cell respiration. The respiratory
rate is primarily dictated by the cells requirements for
adenosine triphosphate (ATP) and may be physiologi-
cally regulated by cellular levels of nitric oxide [25]. Un-
der conditions of diminished tissue blood flow (ischemia),
where physiologic cellular oxygen demand is not met by
the vascular supply, hypoxia ensues. Hypoxia is impor-
tant in cellular as well as whole organ pathophysiology
[4–6] in a diverse array of disease states and has been
classically associated with the induction of an adaptive
phenotype mediated primarily through accumulation of
the hypoxia-inducible factor (HIF-1) [7].
A recent paradigm has demonstrated an association
between hypoxia and chronic inflammation. In the in-
testine, microvascular disruption (resulting in mucosal
ischemia/hypoxia) due to chronic inflammation may con-
tribute significantly to the pathogenesis of inflammatory
bowel disease (IBD) [8–11]. Because of its juxtaposition
with the anoxic lumen of the gut, the intestinal epithe-
lium relies heavily on the rich mucosal vascular bed for
oxygen supply and is consequently highly susceptible to
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hypoxic/ischemic insult. As disruption of intestinal ep-
ithelial cell function plays a major role in the patho-
genesis of IBD, the impact of hypoxia on this cell type
is of primary interest. We have described pathophysi-
ologic alterations in intestinal epithelial cell phenotype
and function in response to hypoxia [12–14]. Transfor-
mation to this hypoxia-elicited phenotype is critically
dependent upon altered activity of the cyclic adenosine
monophosphate (cAMP) response element binding pro-
tein (CREB). Here we review our understanding of the
molecular mechanisms by which hypoxia regulates in-
testinal epithelial cell function.
AUTOCRINE REGULATION OF INTESTINAL
EPITHELIAL PERMEABILITY IN HYPOXIA
The epithelium is a monolayer of cells which lines
the mucosal surface of the gastrointestinal tract. Conse-
quently, it forms an important barrier preventing the free
mixing of luminal antigenic material with the lamina pro-
pria which houses the mucosal immune system [15, 16].
It is the disruption of this barrier and subsequent unregu-
lated exposure of the mucosal immune system to luminal
antigenic material which underlies chronic inflammatory
processes in IBD. The epithelial barrier is maintained by
the existence of tight junctions between cells. Tight junc-
tions are dynamic structures, the permeability of which
is a highly regulated process. A range of inflammatory
cytokines have been demonstrated to be important in
paracrine regulation of the dynamic epithelial barrier in
both health and disease [17].
Under normal physiologic conditions, mucosal organs
such as the intestine are richly supplied with blood (and
consequently oxygen) by the mucosal microvasculature.
In chronic inflammatory conditions, disruption of the mu-
cosal microvasculature occurs in conjunction with fibrosis
in the lamina propria [8, 9]. These events lead to ineffi-
cient blood supply to the intestinal epithelium rendering
the cells ischemic. Consequently, epithelial oxygen de-
mand exceeds supply and hypoxia ensues. Furthermore,
mucosal hypoxia in IBD has been directly demonstrated
by measuring gut surface oxygen levels [3]. Thus, an
underlying component of IBD may be microvascular dis-
ease leading to mucosal hypoxia.
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Fig. 1. Autocrine regulation of intestinal epithelial permeability in hy-
poxia. Mucosal hypoxia occurs coincidentally with inflammation in
chronic mucosal inflammatory disease. Hypoxia-elicited epithelial tu-
mor necrosis factor-alpha (TNF-a) synergizes with immune cell-derived
interferon-gamma (IFN-c) to cause increased epithelial permeability,
an event which leads to the non-specific movement of luminal antigenic
material to the lamina propria, which houses the mucosal immune sys-
tem, thus potentiating the inflammatory state.
Interactions between hypoxia and inflammation are
further exemplified by evidence that mucosal ischemia
caused by multifocal thrombotic microvascular infarc-
tions may be important in initiating and propagating in-
flammatory events associated with ulcerative colitis and
Crohn’s disease [9, 11]. Furthermore, the incidence of
such disease is significantly diminished in patients with
coagulation disorders such as hemophilia [10].
Using a reductionist approach, we have investigated
the impact of hypoxia on intestinal epithelial cell func-
tion in vitro. Exposure of intestinal epithelial cells to am-
bient hypoxia resulted in the stabilization of HIF-1a and
the subsequent up-regulation of intestinal trefoil factor
(ITF), an important protector of epithelial barrier func-
tion [23]. Such an event may constitute a component
of the adaptive response to hypoxia-elicited injury. We
further identified a distinct proinflammatory response to
hypoxia in intestinal epithelial cells in vitro that is HIF-
1a–independent and occurs temporally downstream of
the adaptive response [18]. This response involves de-
creased ion and fluid transport, increased paracellular
permeability and a decreased capacity of intestinal ep-
ithelial monolayers to restitute following immune cell
transmigration [14, 19]. Because of the potential im-
portance of hypoxia-elicited epithelial dysfunction in
contributing to the pathogenesis of chronic inflamma-
tion in the intestine, we investigated the pathways in-
volved in such responses. We found that a primary cause
of hypoxia-elicited cellular dysfunction was mediated
through the basolaterally polarized release of epithe-
lial tumor necrosis factor-alpha (TNF-a). This TNF-a
acted synergistically with immune cell-derived proinflam-
matory mediators such as interferon gamma (IFN-c) to
actively contribute to inflammatory processes through
decreasing epithelial barrier function (Fig. 1) [14], a hall-
mark of IBD. Furthermore, inhibition of hypoxia-induced
TNF-a release using thalidomide or neutralizing antibod-
ies reversed the hypoxia-elicited phenotype [14]. Thus,
hypoxia-induced epithelial TNF-a may play an important
role in mediating the chronic pathogenesis of mucosal in-
flammatory conditions such as IBD. Because TNF-a is a
major therapeutic target in IBD, we further investigated
the molecular mechanisms underlying hypoxia-elicited
expression.
CRITICAL ROLE OF CREB IN
HYPOXIA-ELICITED EPITHELIAL TNF-a
We extended our studies to investigate other inflam-
matory mediators and found that hypoxia induced an ar-
ray of genes, the expression of which is associated with
inflammation, including interleukin (IL)-8 and major his-
tocompatibility complex (MHC) class II [13]. Bioinfor-
matic analysis revealed that a common factor in the
promoters of inflammatory genes induced in hypoxia was
the presence of a cAMP response element (CRE). CRE
is a consensus motif that binds CREB. Using the TNF-
a promoter as a model, we demonstrated that CREB
acts as a repressor for this gene and that its degradation
in hypoxia removes repressor activity. This critical event
in conjunction with the activation of other transcription
factors such as nuclear factor-jB (NF-jB) results in the
induction of a proinflammatory response to hypoxia [13].
These data uncovered a novel role for the degradation of
CREB in intestinal epithelial cell responses to hypoxia
which is important in the induction and propagation of a
pathophysiologic state.
MECHANISM OF HYPOXIA-ELICITED
CREB DEGRADATION
We set out to investigate the signaling events in-
volved in the targeting of CREB to degradation in
hypoxia. A primary mechanism by which the expres-
sion/activation of transcriptional regulators is controlled
is through degradation via the ATP-dependent ubiqui-
tin/proteasome pathway [20, 21]. Previously defined tran-
scriptional regulators which are targets for this pathway
include b-catenin and IjB, both of which can be directed
to the proteasome in a manner dependent upon biphos-
phorylation of serine residues at defined targeting mo-
tifs (DSXXXS) [22]. We identified, for the first time, an
analogous targeting sequence within CREB (DSVTDS)
which becomes phosphorylated in hypoxia leading to
ubiquitination and degradation via the proteasome [12].
This sequence is distinct from the previously described
Ser133 phosphorylation site involved in activation of
CREB-dependent transcriptional activity. Thus, hypoxia-
dependent phosphorylation of CREB leads to its ubiqui-
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Fig. 2. Phosphorylation-dependent targeting of cyclic adenosine
monophosphate (cAMP) response element binding protein (CREB)
to ubiquitination/degradation in hypoxia. In normoxia, CREB is main-
tained in its unphosphorylated (stable) state through the activity of
PP1c. Under these conditions, CREB acts as a repressor of tumor necro-
sis factor-alpha (TNF-a) transcription. In hypoxia, decreased PP1c ac-
tivity leads to CREB phosphorylation, ubiquitination and degradation.
Coincidentally IjB is degraded, nuclear factor-jB (NF-jB) becomes
activated and transcription of the TNF-a gene ensues.
tination and degradation, a primary event in the induction
of an inflammatory intestinal epithelial phenotype.
Using a global approach we investigated potential sig-
naling events which may be responsible for CREB phos-
phorylation in hypoxia. Gene array analysis revealed a
dramatic decrease in the expression of mRNA for the
serine-threonine phosphatase PP1c, an enzyme previ-
ously associated with the dephosphorylation of CREB.
We demonstrated that hypoxia-elicited CREB phospho-
rylation and subsequent degradation is due at least in
part to decreased activity of PP1c (Fig. 2) [12], although
whether this is solely due to decreased expression of PP1c
or whether endogenous inhibitory proteins [26] are in-
volved is yet to be fully elucidated. This work identi-
fied the regulation of PP1c activity as a major target for
hypoxia-elicited inflammatory events.
In summary, hypoxia elicits an inflammatory pheno-
type in intestinal epithelial cells which actively con-
tributes to disease processes primarily through disruption
of epithelial barrier function. This phenotype is de-
pendent upon the phosphorylation-dependent targeting
of CREB to degradation mediated through decreased
PP1c activity/expression. Diminished CREB results in
decreased repressor activity, an event which in tandem
with the activation of proinflammatory transcriptional
regulators such as NF-jB enhances the transcription
of genes such as TNF-a. Increased expression of such
important inflammatory regulators may have a signifi-
cant impact on the pathophysiology of inflammatory dis-
orders where inflammation occurs concomitantly with
hypoxia.
FUTURE CONSIDERATIONS: RESOLUTION OF
HYPOXIA-ELICITED INFLAMMATORY EVENTS
An important component of the inflammatory re-
sponse is the capacity of cells and tissues to undergo a res-
olution phase thus limiting inflammatory tissue damage
[27]. As targeted degradation of transcriptional regula-
tors such as IjB and CREB via the ubiquitin/proteasome
pathway represents an important inflammatory “on-
switch,” the stabilization of such proteins is a potential
mechanism of resolution. One method of inhibition of
ubiquitin-dependent transcription factor activation is the
posttranslational modification of transcription factors by
the small ubiquitin-related modifier (SUMO-1). SUMO-
1 has been previously demonstrated to inhibit ubiquiti-
nation of IjB [24]. We have found that hypoxia-elicited
inflammatory gene expression is a transient event which
is resolved at later time points, an event which is associ-
ated with the evolution of a high-molecular-weight form
of CREB (unpublished data). Future studies will deter-
mine whether modifications of CREB such as sumoyla-
tion may have a role to play in the resolution of hypoxia-
elicited inflammatory events in prolonged periods of
exposure.
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